Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FIAGEN T3 UPTAKE CATALOGUE #101-402

K-Number: K895186 · 1989-11-08

ApplicantCyberfluor, Inc.
Decision Date1989-11-08
Product CodeKHQ
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

FIAGEN T3 UPTAKE CATALOGUE #101-402 is the device name listed in this FDA 510(k) record. The listed applicant is Cyberfluor, Inc.. It received FDA 510(k) clearance on 1989-11-08 under 510(k) number K895186. The device is classified under product code KHQ. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FIAGEN T3 UPTAKE CATALOGUE #101-402?

FIAGEN T3 UPTAKE CATALOGUE #101-402 is a medical device that received FDA 510(k) clearance on 1989-11-08. The listed applicant is Cyberfluor, Inc.. The 510(k) number is K895186.

When did FIAGEN T3 UPTAKE CATALOGUE #101-402 receive FDA 510(k) clearance?

FIAGEN T3 UPTAKE CATALOGUE #101-402 received FDA 510(k) clearance on 1989-11-08, under 510(k) number K895186.

Who is the listed applicant for FIAGEN T3 UPTAKE CATALOGUE #101-402?

The FDA 510(k) record lists Cyberfluor, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FIAGEN T3 UPTAKE CATALOGUE #101-402?

The FDA product code for FIAGEN T3 UPTAKE CATALOGUE #101-402 is KHQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Cyberfluor, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K923410FIAGEN PROGESTERONEK905656FLAGEN TRIIODOTHYRONINE (T3) ASSAYK904539FLAGEN TM FREE T4K900621FIAGEN(TM) HLH.SK895396CYBERFLUOR FIAGEN TSHK884707FIAGEN DIGOXIN TIME-RESOLVED FLUOROIMMUNOASSAY KIT

View all 17 devices →

Related Devices (Code: KHQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K981375ACE T UPTAKE REAGENT TU CALIBRATORSSchiapparelli Biosystems, Inc.K980088T-UPTAKE MICROPLATE EIAMonobindK970539CHIRON DIAGNOSTICS ACS:180TU PChiron Diagnostics Corp.K964308VITROS IMMUNODIAGNOSTICS PRODUCTS T3 UPTAKE REAGENT PACK (GEM.1025) AND T3 UPTAKE CALIBRATORS (GEM.C025)Johnson & Johnson Clinical Diagnostics, Inc.K961488ELECSYS T-UPTAKE ASSAYBoehringer Mannheim Corp.K954807CEDIA T UPTAKE ASSAYBoehringer Mannheim Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑